Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.

Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.

Physicians at Weill Cornell Medicine reviewed the diagnostic criteria for diabetes in pregnancy; types of therapies available to prevent hyperglycemia; and strategies for reaching inpatient glycemic targets during the peripartum period.

Dr. Goncalves has developed a mouse model that recapitulates the cachexia syndrome as they seek interventions – either dietary or metabolic – to help prevent muscle wasting and fat loss.

We found that insulin production decreases long before a patient is actually diagnosed with type 1 diabetes. Now that we know that a reduction in insulin production begins earlier on, we can diagnose T1D earlier in patients with antibody screening.

The New York Obesity Nutrition Research Center at Columbia University Irving Medical Center continues to pursue groundbreaking discoveries about the causes, complications, and treatment of obesity that are translating into effective interventions across the lifespan.

On February 1, 2018, Anthony N. Hollenberg, MD, a physician-scientist specializing in endocrinology, joined Weill Cornell as Chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and Physician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center.

“While helping to run the morgue at Ground Zero, I remember excusing myself and going over to a burned-out corner to check my blood sugar,” says Dr. Baker.